Investor Overview

Corporate Profile

Investor Highlights

Corporate Profile

Read Now

Corporate Profile

Investor Presentation

Read Now


Our Pipeline

Learn More
  • Price
  • Change

  • Copyright West LLC.
    Minimum 15 minutes delayed.
Recent Releases

Recent Releases

August 6, 2020

BeiGene Reports Second Quarter 2020 Financial Results

August 5, 2020

BeiGene Announces Data on Tislelizumab and Pamiparib to Be Presented at the 2020 European Society for Medical Oncology (ESMO) Virtual Congress

July 27, 2020

Priority Review Granted to BeiGene’s New Drug Application of Pamiparib in Ovarian Cancer in China

Key Metrics

Key Metrics

  • 4,100+


  • 1,100+

    Clinical team

  • 5


This website uses cookies to improve your overall experience. With your continued use, you are agreeing to accept our use of cookies.